Human Adaptation of Ebola Virus during the West African Outbreak

Cell

Volumn 167, Issue 4, 2016, Pages 1079-1087.e5

  Urbanowicz, Richard A ^a   McClure, C Patrick ^a   Sakuntabhai, Anavaj ^b,c   Sall, Amadou A ^d   Kobinger, Gary ^e,f   Müller, Marcel A ^g   Holmes, Edward C ^h   Rey, Félix A ^b,c   Simon Loriere, Etienne ^b,c   Ball, Jonathan K ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b INSTITUT PASTEUR   (France)

^c CNRS   (France)

^d Institut Pasteur de Dakar   (France)

^e PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^f UNIVERSITY OF MANITOBA   (Canada)

^g UNIVERSITY HOSPITAL BONN   (Germany)

^h University of Sydney   (Australia)

Author keywords

adaptation; bat; Ebola virus; epistasis; evolution; human; Makona; pseudovirus; tropism

Indexed keywords

GLYCOPROTEIN; ENVELOPE GLYCOPROTEIN, EBOLA VIRUS; VIRUS ENVELOPE PROTEIN;

ADAPTATION; AMINO ACID SUBSTITUTION; ARTICLE; EBOLAVIRUS; EPIDEMIC; HUMAN; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; TROPISM; VIRUS GENOME; VIRUS INFECTIVITY; VIRUS TRANSMISSION; WEST AFRICAN; AFRICA; ANIMAL; BAT; CLASSIFICATION; EVOLUTION; GENETICS; HEMORRHAGIC FEVER, EBOLA; HOST RANGE; METABOLISM; MUTATION; PATHOGENICITY; PHYSIOLOGY; TRANSMISSION; VIROLOGY; ZOONOSIS;

AFRICA, WESTERN; ANIMALS; BIOLOGICAL EVOLUTION; CHIROPTERA; DISEASE OUTBREAKS; EBOLAVIRUS; HEMORRHAGIC FEVER, EBOLA; HOST SPECIFICITY; HUMANS; MUTATION; PHYLOGENY; VIRAL ENVELOPE PROTEINS; ZOONOSES;

EID: 84994772093     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2016.10.013     Document Type: Article

References (45)

1. Anisimova, M., Gascuel, O., Approximate likelihood-ratio test for branches: A fast, accurate, and powerful alternative. Syst. Biol. 55 (2006), 539–552.
2. Azarian, T., Lo Presti, A., Giovanetti, M., Cella, E., Rife, B., Lai, A., Zehender, G., Ciccozzi, M., Salemi, M., Impact of spatial dispersion, evolution, and selection on Ebola Zaire Virus epidemic waves. Sci. Rep., 5, 2015, 10170.
3. Besnier, C., Ylinen, L., Strange, B., Lister, A., Takeuchi, Y., Goff, S.P., Towers, G.J., Characterization of murine leukemia virus restriction in mammals. J. Virol. 77 (2003), 13403–13406.
4. Capobianchi, M.R., Gruber, C.E., Carletti, F., Meschi, S., Castilletti, C., Vairo, F., Biava, M., Minosse, C., Strada, G., Portella, G., et al. Molecular signature of the ebola virus associated with the fishermen community outbreak in Aberdeen, Sierra Leone, in February 2015. Genome Announc., 2015 Published online September 24, 2015 https://dx.doi.org/10.1128/genomeA.01093-15.
5. Carroll, M.W., Matthews, D.A., Hiscox, J.A., Elmore, M.J., Pollakis, G., Rambaut, A., Hewson, R., Garcia-Dorival, I., Bore, J.A., Koundouno, R., et al. Temporal and spatial analysis of the 2014-2015 Ebola virus outbreak in West Africa. Nature 524 (2015), 97–101.
6. Diehl, W.E., Lin, A.E., Grubaugh, N.D., Carvalho, L.M., Kyusik, K., Kyawe, P.P., McCauley, S.M., Donnard, E., Kucukural, A., McDonel, P., et al. Ebola virus glycoprotein with increased infectivity dominated the 2013-2016 epidemic. Cell 167 (2016), 1088–1098 this issue.
7. Faye, O., Andronico, A., Faye, O., Salje, H., Boëlle, P.Y., Magassouba, N., Bah, E.I., Koivogui, L., Diallo, B., Diallo, A.A., et al. Use of Viremia to Evaluate the Baseline Case Fatality Ratio of Ebola Virus Disease and Inform Treatment Studies: A Retrospective Cohort Study. PLoS Med., 12, 2015, e1001908.
8. Fitzpatrick, G., Vogt, F., Moi Gbabai, O.B., Decroo, T., Keane, M., De Clerck, H., Grolla, A., Brechard, R., Stinson, K., Van Herp, M., The Contribution of Ebola Viral Load at Admission and Other Patient Characteristics to Mortality in a Medecins Sans Frontieres Ebola Case Management Centre, Kailahun, Sierra Leone, June-October 2014. J. Infect. Dis. 212 (2015), 1752–1758.
9. Gire, S.K., Goba, A., Andersen, K.G., Sealfon, R.S., Park, D.J., Kanneh, L., Jalloh, S., Momoh, M., Fullah, M., Dudas, G., et al. Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak. Science 345 (2014), 1369–1372.
10. Gong, X., Qian, H., Zhou, X., Wu, J., Wan, T., Cao, P., Huang, W., Zhao, X., Wang, X., Wang, P., et al. Structural Insights into the Niemann-Pick C1 (NPC1)-Mediated Cholesterol Transfer and Ebola Infection. Cell 165 (2016), 1467–1478.
11. Guindon, S., Dufayard, J.F., Lefort, V., Anisimova, M., Hordijk, W., Gascuel, O., New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0. Syst. Biol. 59 (2010), 307–321.
12. Han, B.A., Schmidt, J.P., Alexander, L.W., Bowden, S.E., Hayman, D.T., Drake, J.M., Undiscovered Bat Hosts of Filoviruses. PLoS Negl. Trop. Dis., 10, 2016, e0004815.
13. Herrera, C., Klasse, P.J., Michael, E., Kake, S., Barnes, K., Kibler, C.W., Campbell-Gardener, L., Si, Z., Sodroski, J., Moore, J.P., Beddows, S., The impact of envelope glycoprotein cleavage on the antigenicity, infectivity, and neutralization sensitivity of Env-pseudotyped human immunodeficiency virus type 1 particles. Virology 338 (2005), 154–172.
14. Hoenen, T., Safronetz, D., Groseth, A., Wollenberg, K.R., Koita, O.A., Diarra, B., Fall, I.S., Haidara, F.C., Diallo, F., Sanogo, M., et al. Virology. Mutation rate and genotype variation of Ebola virus from Mali case sequences. Science 348 (2015), 117–119.
15. Kuhl, A., Hoffmann, M., Muller, M.A., Munster, V.J., Gnirss, K., Kiene, M., Tsegaye, T.S., Behrens, G., Herrler, G., Feldmann, H., et al. Comparative analysis of Ebola virus glycoprotein interactions with human and bat cells. J. Infect. Dis. 204:Suppl 3 (2011), S840–S849.
16. Ladner, J.T., Wiley, M.R., Mate, S., Dudas, G., Prieto, K., Lovett, S., Nagle, E.R., Beitzel, B., Gilbert, M.L., Fakoli, L., et al. Evolution and Spread of Ebola Virus in Liberia, 2014-2015. Cell Host Microbe 18 (2015), 659–669.
17. Lee, J.E., Fusco, M.L., Hessell, A.J., Oswald, W.B., Burton, D.R., Saphire, E.O., Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor. Nature 454 (2008), 177–182.
18. Leendertz, S.A., Gogarten, J.F., Düx, A., Calvignac-Spencer, S., Leendertz, F.H., Assessing the Evidence Supporting Fruit Bats as the Primary Reservoirs for Ebola Viruses. EcoHealth 13 (2016), 18–25.
19. Lennemann, N.J., Rhein, B.A., Ndungo, E., Chandran, K., Qiu, X., Maury, W., Comprehensive functional analysis of N-linked glycans on Ebola virus GP1. MBio, 5, 2014 e00862–e13.
20. Leroy, E.M., Kumulungui, B., Pourrut, X., Rouquet, P., Hassanin, A., Yaba, P., Délicat, A., Paweska, J.T., Gonzalez, J.P., Swanepoel, R., Fruit bats as reservoirs of Ebola virus. Nature 438 (2005), 575–576.
21. Liu, S.Q., Deng, C.L., Yuan, Z.M., Rayner, S., Zhang, B., Identifying the pattern of molecular evolution for Zaire ebolavirus in the 2014 outbreak in West Africa. Infect. Genet. Evol. 32 (2015), 51–59.
22. Marí Saéz, A., Weiss, S., Nowak, K., Lapeyre, V., Zimmermann, F., Düx, A., Kühl, H.S., Kaba, M., Regnaut, S., Merkel, K., et al. Investigating the zoonotic origin of the West African Ebola epidemic. EMBO Mol. Med. 7 (2014), 17–23.
23. Martinez, O., Ndungo, E., Tantral, L., Miller, E.H., Leung, L.W., Chandran, K., Basler, C.F., A mutation in the Ebola virus envelope glycoprotein restricts viral entry in a host species- and cell-type-specific manner. J. Virol. 87 (2013), 3324–3334.
24. Marzi, A., Akhavan, A., Simmons, G., Gramberg, T., Hofmann, H., Bates, P., Lingappa, V.R., Pöhlmann, S., The signal peptide of the ebolavirus glycoprotein influences interaction with the cellular lectins DC-SIGN and DC-SIGNR. J. Virol. 80 (2006), 6305–6317.
25. Mohan, G.S., Ye, L., Li, W., Monteiro, A., Lin, X., Sapkota, B., Pollack, B.P., Compans, R.W., Yang, C., Less is more: Ebola virus surface glycoprotein expression levels regulate virus production and infectivity. J. Virol. 89 (2015), 1205–1217.
26. Moncla, L.H., Zhong, G., Nelson, C.W., Dinis, J.M., Mutschler, J., Hughes, A.L., Watanabe, T., Kawaoka, Y., Friedrich, T.C., Selective Bottlenecks Shape Evolutionary Pathways Taken during Mammalian Adaptation of a 1918-like Avian Influenza Virus. Cell Host Microbe 19 (2016), 169–180.
27. Nakabayashi, H., Taketa, K., Miyano, K., Yamane, T., Sato, J., Growth of human hepatoma cells lines with differentiated functions in chemically defined medium. Cancer Res. 42 (1982), 3858–3863.
28. Ng, M., Ndungo, E., Kaczmarek, M.E., Herbert, A.S., Binger, T., Kuehne, A.I., Jangra, R.K., Hawkins, J.A., Gifford, R.J., Biswas, R., et al. Filovirus receptor NPC1 contributes to species-specific patterns of ebolavirus susceptibility in bats. eLife, 4, 2015, e11785.
29. Ogawa, H., Miyamoto, H., Nakayama, E., Yoshida, R., Nakamura, I., Sawa, H., Ishii, A., Thomas, Y., Nakagawa, E., Matsuno, K., et al. Seroepidemiological Prevalence of Multiple Species of Filoviruses in Fruit Bats (Eidolon helvum) Migrating in Africa. J. Infect. Dis. 212:Suppl 2 (2015), S101–S108.
30. Olabode, A.S., Jiang, X., Robertson, D.L., Lovell, S.C., Ebolavirus is evolving but not changing: No evidence for functional change in EBOV from 1976 to the 2014 outbreak. Virology 482 (2015), 202–207.
31. Olal, D., Kuehne, A.I., Bale, S., Halfmann, P., Hashiguchi, T., Fusco, M.L., Lee, J.E., King, L.B., Kawaoka, Y., Dye, J.M. Jr., Saphire, E.O., Structure of an antibody in complex with its mucin domain linear epitope that is protective against Ebola virus. J. Virol. 86 (2012), 2809–2816.
32. Pepin, K.M., Lass, S., Pulliam, J.R., Read, A.F., Lloyd-Smith, J.O., Identifying genetic markers of adaptation for surveillance of viral host jumps. Nat. Rev. Microbiol. 8 (2010), 802–813.
33. Pourrut, X., Délicat, A., Rollin, P.E., Ksiazek, T.G., Gonzalez, J.P., Leroy, E.M., Spatial and temporal patterns of Zaire ebolavirus antibody prevalence in the possible reservoir bat species. J. Infect. Dis. 196:Suppl 2 (2007), S176–S183.
34. Pourrut, X., Souris, M., Towner, J.S., Rollin, P.E., Nichol, S.T., Gonzalez, J.P., Leroy, E., Large serological survey showing cocirculation of Ebola and Marburg viruses in Gabonese bat populations, and a high seroprevalence of both viruses in Rousettus aegyptiacus. BMC Infect. Dis., 9, 2009, 159.
35. Quick, J., Loman, N.J., Duraffour, S., Simpson, J.T., Severi, E., Cowley, L., Bore, J.A., Koundouno, R., Dudas, G., Mikhail, A., et al. Real-time, portable genome sequencing for Ebola surveillance. Nature 530 (2016), 228–232.
36. Reddel, R.R., Yang, K., Rhim, J.S., Brash, D., Su, R.T., Lechner, J.F., Gerwin, B.I., Harris, C.C., and Amstad, P. December 1989. Immortalized human bronchial epithelial mesothelial cell lines. U.S. patent US4885238 A.
37. Schieffelin, J.S., Shaffer, J.G., Goba, A., Gbakie, M., Gire, S.K., Colubri, A., Sealfon, R.S., Kanneh, L., Moigboi, A., Momoh, M., et al. KGH Lassa Fever Program Viral Hemorrhagic Fever Consortium, WHO Clinical Response Team. Clinical illness and outcomes in patients with Ebola in Sierra Leone. N. Engl. J. Med. 371 (2014), 2092–2100.
38. Simon-Loriere, E., Faye, O., Faye, O., Koivogui, L., Magassouba, N., Keita, S., Thiberge, J.M., Diancourt, L., Bouchier, C., Vandenbogaert, M., et al. Distinct lineages of Ebola virus in Guinea during the 2014 West African epidemic. Nature 524 (2015), 102–104.
39. Smith, B.T., Cell line A549: a model system for the study of alveolar type II cell function. Am. Rev. Respir. Dis. 115 (1977), 285–293.
40. Swanepoel, R., Leman, P.A., Burt, F.J., Zachariades, N.A., Braack, L.E., Ksiazek, T.G., Rollin, P.E., Zaki, S.R., Peters, C.J., Experimental inoculation of plants and animals with Ebola virus. Emerg. Infect. Dis. 2 (1996), 321–325.
41. Tong, Y.G., Shi, W.F., Di, L., Qian, J., Liang, L., Bo, X.C., Liu, J., Ren, H.G., Fan, H., Ni, M., et al. Genetic diversity and evolutionary dynamics of Ebola virus in Sierra Leone. Nature 524 (2015), 93–96.
42. Urbanowicz, R.A., McClure, C.P., King, B., Mason, C.P., Ball, J.K., Tarr, A.W., Novel functional hepatitis C virus glycoprotein isolates identified using an optimized viral pseudotype entry assay. J. Gen. Virol. 97 (2016), 2265–2279.
43. Wang, H., Shi, Y., Song, J., Qi, J., Lu, G., Yan, J., Gao, G.F., Ebola Viral Glycoprotein Bound to Its Endosomal Receptor Niemann-Pick C1. Cell 164 (2016), 258–268.
44. W.H.O. (2016). Ebola Situation Report, W.H. Organisation, ed.
45. Yap, M.W., Colbeck, E., Ellis, S.A., Stoye, J.P., Evolution of the retroviral restriction gene Fv1: inhibition of non-MLV retroviruses. PLoS Pathog., 10, 2014, e1003968.